T2 Biosystems Inc. (NASDAQ: TTOO) has seen a decline in its stock price by -7.05 in relation to its previous close of 0.11. However, the company has experienced a -61.05% decline in its stock price over the last five trading sessions.
Is It Worth Investing in T2 Biosystems Inc. (NASDAQ: TTOO) Right Now?
while the 36-month beta value is 0.34.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 3 as “hold,” and 0 as “sell.”
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
The average price point forecasted by analysts for T2 Biosystems Inc. (TTOO) is $0.16, The public float for TTOO is 20.09M, and currently, short sellers hold a 2.37% ratio of that floaft. The average trading volume of TTOO on May 26, 2023 was 1.30M shares.
TTOO’s Market Performance
TTOO’s stock has seen a -61.05% decrease for the week, with a -67.64% drop in the past month and a -81.26% fall in the past quarter. The volatility ratio for the week is 36.74%, and the volatility levels for the past 30 days are at 13.16% for T2 Biosystems Inc. The simple moving average for the past 20 days is -61.06% for TTOO’s stock, with a -95.22% simple moving average for the past 200 days.
TTOO Trading at -71.39% from the 50-Day Moving Average
After a stumble in the market that brought TTOO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -99.29% of loss for the given period.
Volatility was left at 13.16%, however, over the last 30 days, the volatility rate increased by 36.74%, as shares sank -67.64% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -79.80% lower at present.
During the last 5 trading sessions, TTOO fell by -61.05%, which changed the moving average for the period of 200-days by -98.23% in comparison to the 20-day moving average, which settled at $0.2631. In addition, T2 Biosystems Inc. saw -92.48% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at TTOO starting from Gibbs Michael Terrence, who sale 239 shares at the price of $0.48 back on Mar 28. After this action, Gibbs Michael Terrence now owns 6,612 shares of T2 Biosystems Inc., valued at $115 using the latest closing price.
Sperzel John J III, the Chairman and CEO of T2 Biosystems Inc., sale 2,898 shares at $0.59 during a trade that took place back on Feb 28, which means that Sperzel John J III is holding 17,329 shares at $1,710 based on the most recent closing price.
Stock Fundamentals for TTOO
Current profitability levels for the company are sitting at:
- -242.30 for the present operating margin
- +6.07 for the gross margin
The net margin for T2 Biosystems Inc. stands at -277.98. The total capital return value is set at -166.34, while invested capital returns managed to touch -200.56. Equity return is now at value 185.40, with -149.40 for asset returns.
When we switch over and look at the enterprise to sales, we see a ratio of 3.02, with the company’s debt to enterprise value settled at 1.05. The receivables turnover for the company is 6.11 and the total asset turnover is 0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.91.
In a nutshell, T2 Biosystems Inc. (TTOO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.